Avicenna Biosciences, Inc.
- Biotech or pharma, therapeutic R&D
Avicenna is accelerating drug discovery's last mile, solving the intractable design challenges that previously stopped drug candidates in their tracks. The company is developing assets for neurodegenerative disorders, metabolic diseases, and cancer.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}